Reaction: Lacosamide to 1 product

Reaction
Lacosamide
DB06218
O-Desmethyl lacosamide
DBMET00965
Reaction type
O-demethylation
Direction
Major circulating metabolite?
No
Spontaneous?
No
Activity
inactive
References
  1. FDA Approved Drug Products: VIMPAT (lacosamide) intravenous injection or oral solution or tablets (October 2023) [Link]
Comments
Not Available
Enzymes
EnzymeKmVmaxRole
Cytochrome P450 3A4Not AvailableNot Availableimplied
Cytochrome P450 2C9Not AvailableNot Availableimplied
Cytochrome P450 2C19Not AvailableNot Availableimplied